Evidence map›Paper›PMID 16049652›Full record

ArticleZeitschrift fur Kardiologie2005

Euro heart failure survey. Medical treatment not in line with current guidelines.

K Drechsler, R Dietz, H Klein, K C Wollert, D Storp, J Molling, U Zeymer, J Niebauer

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Kardiologie, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Implementation of evidence-based therapy in patients with systolic heart failure from 1998-2000.Clinical research in cardiology : official journal of the German Cardiac Society · 2006
    Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure.Clinical research in cardiology : official journal of the German Cardiac Society · 2012
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Beta blockers and glucose metabolism in chronic heart failure: friend or foe?Clinical research in cardiology : official journal of the German Cardiac Society · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

K DrechslerUniversität Leipzig-Herzzentrum, Leipzig, Germany.
R Dietz
H Klein
K C Wollert
D Storp
J Molling
U Zeymer
J Niebauer
Charité - Universitätsmedizin Berlin · DEDeutsches Herzzentrum der Charité · DEKlinikum Ludwigshafen · DEKlinikum Magdeburg · DEKRH Klinikum Agnes Karll Laatzen · DEMedizinische Hochschule Hannover · DESalzburger Landeskliniken · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledIt was the aim of the Euro Heart Survey on Heart Failure to assess whether patients are being treated according to current guidelines.

methodsIn Germany, patients were screened in 7 medical centers if their discharge diagnoses were myocardial infarction, a new episode of atrial fibrillation, or diabetes mellitus. Patients were enrolled if at least one additional criterion was fulfilled: (1) clinical diagnosis of heart failure, (2) hospital admission due to heart failure within the last 3 years, (3) therapy with loop diuretic, (4) medication for heart failure or ventricular dysfunction documented by echocardiography within the past 24 hours prior to death.

results2166 patients were screened of whom 747 were included in the study (478 men, 269 women). 93% of the patients suffered from heart failure. Despite the high number of patients with known heart failure (ischemic heart failure in 71%), only 72% received ACE inhibitors and 62% beta-blockers. Average daily dose met recommendations in only 63% of patients on ACE inhibitors and 54% on beta-blockers. 74% of the patients received diuretics (furosemide 36%, thiazide 34%, spironolactone 17%).

conclusionAn inadequately low number of patients with heart failure receives medical therapy according to guidelines, despite all the overwhelming evidence for improved morbidity and mortality. Awareness of physicians needs to be improved.

Indexed as

Guideline AdherenceAdrenergic beta-AntagonistsAgedAge FactorsAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersCardiovascular AgentsDiureticsDrug Therapy, CombinationEuropeFemaleFibrinolytic AgentsHealth SurveysHeart FailureHumansMaleAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersCardiovascular AgentsDiureticsFibrinolytic AgentsSodium Potassium Chloride Symporter Inhibitors

Identifiers

PMID16049652
OpenAlexW121299851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.